Skip directly to site content Skip directly to page options Skip directly to A-Z link Skip directly to A-Z link Skip directly to A-Z link
Volume 31, Number 2—February 2025
Dispatch

Amebiasis in Mexico, 2014–2023

Alberto Antonio-Campos, Keity J. Farfán-Pira, Alfonso D. Díaz-Fonseca, Carlos Ochoa-Velasco, Paola Hernández-Carranza, and Diana M. Torres-CifuentesComments to Author 
Author affiliation: Instituto Politécnico Nacional, Mexico City, Mexico (A. Antonio-Campos); University of Arkansas, Fayetteville, Arkansas, USA (K.J. Farfán-Pira); Benemérita Universidad Autónoma de Puebla, Puebla, Mexico (A.D. Díaz-Fonseca, C. Ochoa-Velasco, P. Hernández-Carranza, D.M. Torres-Cifuentes)

Main Article

Figure 1

Annual prevalence (cases/100,000 inhabitants) of IIA (A) and ALA (B) in Mexico, by state, 2014–2023. ALA, amebic liver abscess; IIA, intestinal invasive amebiasis.

Figure 1. Annual prevalence (cases/100,000 inhabitants) of IIA (A) and ALA (B) in Mexico, by state, 2014–2023. ALA, amebic liver abscess; IIA, intestinal invasive amebiasis.

Main Article

Page created: January 15, 2025
Page updated: January 31, 2025
Page reviewed: January 31, 2025
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.
file_external